FGFR3 and breast cancer: In past studies, BC was commonly linked to two main genetic pathways, one involving FGFR3 (fibroblast growth factor receptor 3,) mutations, often associated with low-grade tumors and favorable prognosis, and one characterized by TP53 (tumor protein P53) mutations, mainly identified in advanced tumors with poor prognosis [7].